1 | screened | 5,619 |
2 | weighed | 756 |
3 | recalled | 354 |
4 | inspected | 249 |
5 | plotted | 220 |
6 | cleaned | 141 |
7 | scrutinized | 125 |
8 | scrutinised | 58 |
9 | benchmarked | 37 |
10 | seroprotected | 28 |
11 | rescreened | 23 |
12 | phenotyped | 22 |
13 | catalogued | 17 |
14 | prescreened | 16 |
15 | postprocessed | 13 |
16 | rescheduled | 10 |
17 | re-used | 9 |
18 | prayed | 8 |
19 | ≥1:4 | 8 |
20 | cross-tabulated | 7 |
21 | self-tested | 7 |
22 | undervaccinated | 6 |
23 | 'protocol | 5 |
24 | débrided | 5 |
25 | included.the | 5 |
26 | re-enrolled | 5 |
27 | re-explored | 5 |
28 | data-extracted | 4 |
29 | pre-oxygenated | 4 |
30 | underscreened | 4 |
31 | 5721 | 3 |
32 | anesthesized | 3 |
33 | gram-type | 3 |
34 | reinvited | 3 |
35 | selflimiting | 3 |
36 | 2.01±0.43 | 2 |
37 | achieved.however | 2 |
38 | liaised | 2 |
39 | micro-coded | 2 |
40 | nonunique | 2 |
41 | post-wu | 2 |
42 | safety-valid | 2 |
43 | seroprotected/seropositive | 2 |
44 | used-the | 2 |
45 | vortexed | 2 |
46 | €20 | 2 |
47 | €2456 | 2 |
48 | -14.2±0.7 | 1 |
49 | -212.5 | 1 |
50 | -22.4/-14.6 | 1 |
51 | 0.02mg/l | 1 |
52 | 0.075°c | 1 |
53 | 0.40296 | 1 |
54 | 0.85/0.70 | 1 |
55 | 1.2-4.3 | 1 |
56 | 1.6+/-1.4 | 1 |
57 | 1.8points | 1 |
58 | 10.9091 | 1 |
59 | 130.18 | 1 |
60 | 149+/-35 | 1 |
61 | 15,310.56 | 1 |
62 | 1598.0 | 1 |
63 | 17,690 | 1 |
64 | 2.11/0.72 | 1 |
65 | 2.1±5.2 | 1 |
66 | 2.7-10.5 | 1 |
67 | 3.6microm | 1 |
68 | 30.3:6.0 | 1 |
69 | 327g/d | 1 |
70 | 34.85±5.25 | 1 |
71 | 36mg/dl | 1 |
72 | 37,261 | 1 |
73 | 4.70±2.50 | 1 |
74 | 42°/52° | 1 |
75 | 606,884 | 1 |
76 | 623.4/315.2 | 1 |
77 | 8.463 | 1 |
78 | 81-109 | 1 |
79 | 9.82-14.57 | 1 |
80 | 91/1000 | 1 |
81 | 95.1/67.1 | 1 |
82 | 99-178 | 1 |
83 | 991.4 | 1 |
84 | 992.0 | 1 |
85 | anlayzed | 1 |
86 | applied.this | 1 |
87 | avalaible | 1 |
88 | ball-milled | 1 |
89 | blind-tested | 1 |
90 | bow-ride | 1 |
91 | clinically-eligible | 1 |
92 | cmv-igg | 1 |
93 | dual-immunostained | 1 |
94 | euro5734/vyg | 1 |
95 | euro800 | 1 |
96 | evalauted | 1 |
97 | folloowed-up | 1 |
98 | h2db | 1 |
99 | hev-rna | 1 |
100 | irctrp | 1 |
101 | kras-mutation | 1 |
102 | laregely | 1 |
103 | negative-low | 1 |
104 | paraffin-sectioned | 1 |
105 | ph-cycled | 1 |
106 | randomised-2 | 1 |
107 | re-called | 1 |
108 | re-mated | 1 |
109 | re-scanned | 1 |
110 | re-suppressed | 1 |
111 | reaged | 1 |
112 | reselection | 1 |
113 | respected/rewarded | 1 |
114 | rewiewed | 1 |
115 | road-transported | 1 |
116 | saliva-tested | 1 |
117 | self-destructing | 1 |
118 | stool-culture | 1 |
119 | subcoded | 1 |
120 | survival-extinction | 1 |
121 | thermo-cycled | 1 |
122 | tinuously | 1 |
123 | two-group-usual | 1 |
124 | underconsumed | 1 |
125 | v1370 | 1 |
126 | £13,127 | 1 |
127 | €1259 | 1 |
128 | €13,333 | 1 |
129 | €224 | 1 |
130 | €3,612 | 1 |
131 | €3297 | 1 |
132 | €4003.7 | 1 |
133 | €5669 | 1 |
134 | €70.238/€37.208 | 1 |
135 | €7077 | 1 |
136 | €8094 | 1 |
137 | ≥0.84 | 1 |
1 | 'protocol | 5 |
2 | -14.2±0.7 | 1 |
3 | -212.5 | 1 |
4 | -22.4/-14.6 | 1 |
5 | 0.02mg/l | 1 |
6 | 0.075°c | 1 |
7 | 0.40296 | 1 |
8 | 0.85/0.70 | 1 |
9 | 1.2-4.3 | 1 |
10 | 1.6+/-1.4 | 1 |
11 | 1.8points | 1 |
12 | 10.9091 | 1 |
13 | 130.18 | 1 |
14 | 149+/-35 | 1 |
15 | 15,310.56 | 1 |
16 | 1598.0 | 1 |
17 | 17,690 | 1 |
18 | 2.01±0.43 | 2 |
19 | 2.11/0.72 | 1 |
20 | 2.1±5.2 | 1 |
21 | 2.7-10.5 | 1 |
22 | 3.6microm | 1 |
23 | 30.3:6.0 | 1 |
24 | 327g/d | 1 |
25 | 34.85±5.25 | 1 |
26 | 36mg/dl | 1 |
27 | 37,261 | 1 |
28 | 4.70±2.50 | 1 |
29 | 42°/52° | 1 |
30 | 5721 | 3 |
31 | 606,884 | 1 |
32 | 623.4/315.2 | 1 |
33 | 8.463 | 1 |
34 | 81-109 | 1 |
35 | 9.82-14.57 | 1 |
36 | 91/1000 | 1 |
37 | 95.1/67.1 | 1 |
38 | 99-178 | 1 |
39 | 991.4 | 1 |
40 | 992.0 | 1 |
41 | achieved.however | 2 |
42 | anesthesized | 3 |
43 | anlayzed | 1 |
44 | applied.this | 1 |
45 | avalaible | 1 |
46 | ball-milled | 1 |
47 | benchmarked | 37 |
48 | blind-tested | 1 |
49 | bow-ride | 1 |
50 | catalogued | 17 |
51 | cleaned | 141 |
52 | clinically-eligible | 1 |
53 | cmv-igg | 1 |
54 | cross-tabulated | 7 |
55 | data-extracted | 4 |
56 | dual-immunostained | 1 |
57 | débrided | 5 |
58 | euro5734/vyg | 1 |
59 | euro800 | 1 |
60 | evalauted | 1 |
61 | folloowed-up | 1 |
62 | gram-type | 3 |
63 | h2db | 1 |
64 | hev-rna | 1 |
65 | included.the | 5 |
66 | inspected | 249 |
67 | irctrp | 1 |
68 | kras-mutation | 1 |
69 | laregely | 1 |
70 | liaised | 2 |
71 | micro-coded | 2 |
72 | negative-low | 1 |
73 | nonunique | 2 |
74 | paraffin-sectioned | 1 |
75 | ph-cycled | 1 |
76 | phenotyped | 22 |
77 | plotted | 220 |
78 | post-wu | 2 |
79 | postprocessed | 13 |
80 | prayed | 8 |
81 | pre-oxygenated | 4 |
82 | prescreened | 16 |
83 | randomised-2 | 1 |
84 | re-called | 1 |
85 | re-enrolled | 5 |
86 | re-explored | 5 |
87 | re-mated | 1 |
88 | re-scanned | 1 |
89 | re-suppressed | 1 |
90 | re-used | 9 |
91 | reaged | 1 |
92 | recalled | 354 |
93 | reinvited | 3 |
94 | rescheduled | 10 |
95 | rescreened | 23 |
96 | reselection | 1 |
97 | respected/rewarded | 1 |
98 | rewiewed | 1 |
99 | road-transported | 1 |
100 | safety-valid | 2 |
101 | saliva-tested | 1 |
102 | screened | 5,619 |
103 | scrutinised | 58 |
104 | scrutinized | 125 |
105 | self-destructing | 1 |
106 | self-tested | 7 |
107 | selflimiting | 3 |
108 | seroprotected | 28 |
109 | seroprotected/seropositive | 2 |
110 | stool-culture | 1 |
111 | subcoded | 1 |
112 | survival-extinction | 1 |
113 | thermo-cycled | 1 |
114 | tinuously | 1 |
115 | two-group-usual | 1 |
116 | underconsumed | 1 |
117 | underscreened | 4 |
118 | undervaccinated | 6 |
119 | used-the | 2 |
120 | v1370 | 1 |
121 | vortexed | 2 |
122 | weighed | 756 |
123 | £13,127 | 1 |
124 | €1259 | 1 |
125 | €13,333 | 1 |
126 | €20 | 2 |
127 | €224 | 1 |
128 | €2456 | 2 |
129 | €3,612 | 1 |
130 | €3297 | 1 |
131 | €4003.7 | 1 |
132 | €5669 | 1 |
133 | €70.238/€37.208 | 1 |
134 | €7077 | 1 |
135 | €8094 | 1 |
136 | ≥0.84 | 1 |
137 | ≥1:4 | 8 |
1 | 992.0 | 1 |
2 | 30.3:6.0 | 1 |
3 | 1598.0 | 1 |
4 | 91/1000 | 1 |
5 | euro800 | 1 |
6 | €20 | 2 |
7 | 4.70±2.50 | 1 |
8 | 0.85/0.70 | 1 |
9 | v1370 | 1 |
10 | 17,690 | 1 |
11 | 95.1/67.1 | 1 |
12 | 5721 | 3 |
13 | 37,261 | 1 |
14 | 10.9091 | 1 |
15 | randomised-2 | 1 |
16 | 623.4/315.2 | 1 |
17 | 2.1±5.2 | 1 |
18 | €3,612 | 1 |
19 | 2.11/0.72 | 1 |
20 | 1.2-4.3 | 1 |
21 | €13,333 | 1 |
22 | 2.01±0.43 | 2 |
23 | 8.463 | 1 |
24 | 1.6+/-1.4 | 1 |
25 | 991.4 | 1 |
26 | €224 | 1 |
27 | ≥0.84 | 1 |
28 | 606,884 | 1 |
29 | €8094 | 1 |
30 | ≥1:4 | 8 |
31 | 2.7-10.5 | 1 |
32 | -212.5 | 1 |
33 | 34.85±5.25 | 1 |
34 | 149+/-35 | 1 |
35 | -22.4/-14.6 | 1 |
36 | 15,310.56 | 1 |
37 | €2456 | 2 |
38 | 0.40296 | 1 |
39 | -14.2±0.7 | 1 |
40 | €4003.7 | 1 |
41 | £13,127 | 1 |
42 | 9.82-14.57 | 1 |
43 | €7077 | 1 |
44 | €3297 | 1 |
45 | €70.238/€37.208 | 1 |
46 | 130.18 | 1 |
47 | 99-178 | 1 |
48 | 81-109 | 1 |
49 | €1259 | 1 |
50 | €5669 | 1 |
51 | hev-rna | 1 |
52 | h2db | 1 |
53 | 0.075°c | 1 |
54 | 327g/d | 1 |
55 | débrided | 5 |
56 | micro-coded | 2 |
57 | subcoded | 1 |
58 | respected/rewarded | 1 |
59 | reaged | 1 |
60 | weighed | 756 |
61 | benchmarked | 37 |
62 | ph-cycled | 1 |
63 | thermo-cycled | 1 |
64 | re-called | 1 |
65 | recalled | 354 |
66 | ball-milled | 1 |
67 | re-enrolled | 5 |
68 | rescheduled | 10 |
69 | underconsumed | 1 |
70 | cleaned | 141 |
71 | screened | 5,619 |
72 | rescreened | 23 |
73 | prescreened | 16 |
74 | underscreened | 4 |
75 | dual-immunostained | 1 |
76 | re-scanned | 1 |
77 | paraffin-sectioned | 1 |
78 | phenotyped | 22 |
79 | re-explored | 5 |
80 | liaised | 2 |
81 | scrutinised | 58 |
82 | postprocessed | 13 |
83 | re-suppressed | 1 |
84 | re-used | 9 |
85 | cross-tabulated | 7 |
86 | re-mated | 1 |
87 | pre-oxygenated | 4 |
88 | undervaccinated | 6 |
89 | data-extracted | 4 |
90 | inspected | 249 |
91 | seroprotected | 28 |
92 | reinvited | 3 |
93 | road-transported | 1 |
94 | saliva-tested | 1 |
95 | blind-tested | 1 |
96 | self-tested | 7 |
97 | plotted | 220 |
98 | evalauted | 1 |
99 | catalogued | 17 |
100 | rewiewed | 1 |
101 | vortexed | 2 |
102 | prayed | 8 |
103 | scrutinized | 125 |
104 | anesthesized | 3 |
105 | anlayzed | 1 |
106 | safety-valid | 2 |
107 | bow-ride | 1 |
108 | used-the | 2 |
109 | included.the | 5 |
110 | avalaible | 1 |
111 | clinically-eligible | 1 |
112 | gram-type | 3 |
113 | stool-culture | 1 |
114 | nonunique | 2 |
115 | seroprotected/seropositive | 2 |
116 | cmv-igg | 1 |
117 | self-destructing | 1 |
118 | selflimiting | 3 |
119 | euro5734/vyg | 1 |
120 | 0.02mg/l | 1 |
121 | two-group-usual | 1 |
122 | 36mg/dl | 1 |
123 | 'protocol | 5 |
124 | 3.6microm | 1 |
125 | kras-mutation | 1 |
126 | reselection | 1 |
127 | survival-extinction | 1 |
128 | irctrp | 1 |
129 | folloowed-up | 1 |
130 | achieved.however | 2 |
131 | applied.this | 1 |
132 | 1.8points | 1 |
133 | post-wu | 2 |
134 | negative-low | 1 |
135 | laregely | 1 |
136 | tinuously | 1 |
137 | 42°/52° | 1 |